CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	7 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 29, 2016	May 28, 2015	May 29, 2014
Operating activities
Net earnings	$ 23,443	$ 37,539	$ 23,642	$ 20,899
Adjustments to reconcile net earnings to net cash provided by operating activities:
Losses (earnings) on investments in joint ventures	36	(301)	186	250
Distributions from joint ventures	152	560	166	120
Loss on disposition of property, equipment and other assets	490	844	1,463	993
Impairment charge	0	0	2,919	0
Amortization of favorable lease right	194	334	334	334
Depreciation and amortization	23,815	41,832	38,361	33,354
Amortization of debt issuance costs	258	303	449	491
Stock compensation expense	975	1,899	1,499	1,781
Deferred income taxes	(1,079)	3,022	5,614	(451)
Deferred compensation and other	1,564	577	3,531	850
Contribution of the Company’s stock to savings and profit-sharing plan	0	905	888	782
Changes in operating assets and liabilities:
Accounts and notes receivable	2,967	(1,486)	(5,627)	(877)
Other current assets	(388)	(2,465)	(845)	836
Accounts payable	(665)	(1,978)	2,355	748
Income taxes	7,567	(5,124)	(925)	(2,544)
Taxes other than income taxes	2,550	(373)	766	333
Accrued compensation	(3,085)	4,738	2,440	1,974
Other accrued liabilities	8,016	1,829	3,236	6,567
Total adjustments	43,367	45,116	56,810	45,541
Net cash provided by operating activities	66,810	82,655	80,452	66,440
Investing activities
Capital expenditures	(44,452)	(83,606)	(74,988)	(56,673)
Purchase of theatres, net of cash acquired and working capital assumed	0	(63,766)	0	0
Proceeds from disposals of property, equipment and other assets	13,977	1,560	226	1,926
Decrease (increase) in restricted cash	(9,259)	12,553	(728)	(137)
Decrease (increase) in other assets	495	3,572	(786)	(1,227)
Capital contribution in joint venture	0	0	(399)	(1,366)
Purchase of interest in joint venture	(1,600)	0	(1,500)	0
Sale of interest in joint venture	0	1,100	0	0
Cash advanced to joint ventures	0	0	0	(231)
Net cash used in investing activities	(40,839)	(128,587)	(78,175)	(57,708)
Financing activities
Proceeds from borrowings on revolving credit facility	108,500	346,188	162,500	92,500
Repayment of borrowings on revolving credit facility	(126,500)	(236,188)	(148,500)	(115,500)
Proceeds from issuance of long-term debt	0	0	0	52,700
Principal payments on long-term debt	(3,339)	(52,335)	(7,176)	(31,886)
Debt issuance costs	0	(578)	0	(316)
Equity transactions:
Treasury stock transactions, except for stock options	594	(6,089)	(773)	(3,886)
Exercise of stock options	860	3,986	2,964	5,605
Dividends paid	(5,632)	(12,037)	(10,390)	(9,203)
Distributions to noncontrolling interest	(505)	(448)	(959)	(2,124)
Net cash provided by (used in) financing activities	(26,022)	42,499	(2,334)	(12,110)
Net decrease in cash and cash equivalents	(51)	(3,433)	(57)	(3,378)
Cash and cash equivalents at beginning of year	6,723	6,672	6,780	10,158
Cash and cash equivalents at end of year	6,672	3,239	6,723	6,780
Supplemental Information:
Change in accounts payable for additions to property and equipment	(7,370)	3,417	3,467	4,876
Capital leases acquired	0	17,511	0	0
Non-cash contribution in joint venture	$ 400	$ 0	$ 0	$ 0